🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06923163
Recruiting Not applicable

The Effect of Exercise on Metabolic Alteration

NCT06923163 · tracked via the Priya Life Science China tracker
Sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Phase
Not applicable
Started
2025-05-01
Last updated
2026-01-21

Condition(s) studied

Sedentary BehaviorHealthy ParticipantsAdult

Investigational drug(s) / intervention(s)

Exercise intervention

Exercise intervention: Exercise prescription for participant, * 150Kcal for Weeks 1-4 (gradually increase to 150Kcal in the first two weeks as familiar stage), * 250Kcal for Weeks 5-8, * 350Kcal for Weeks 9-12.

Study summary

The goal of this clinical trial is to study the effectiveness of aerobic exercise in treating obesity in adults and to assess the efficacy of exercise. The primary research questions it seeks to address are as follows:

* To what extent does exercise increase the total energy expenditure of participants?
* Why and how does the energy expenditure from exercise not fully compensate for the total energy expenditure (TEE)?
* Researchers will assess the efficacy and potential challenges of using exercise as a treatment for obesity by comparing the measurement data before exercise intervention (week 0), immediately after exercise intervention (week 12), and 8 weeks post-completion of exercise intervention (week 20).

Participants will engage in the following activities:

* Engage in running sessions supervised five times a week for a duration of 12 weeks.
* Attend laboratory sessions both before and after the exercise intervention period for metabolic and anthropometric measurements, as well as sample collection.
* Return to the laboratory for further metabolic and anthropometric measurements and sample collection8 weeks post-completion of exercise intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Sedentary individuals * BMI ≥ 18.5 kg/m2 Exclusion Criteria: * Individuals who have undergone major surgery in the past 6 months (excluding tooth extraction); * Individuals on long-term medication; * Individuals with metabolic and cardiovascular diseases such as diabetes, hypoglycemia, and hypertension; * Individuals with exercise-related injuries, including joint diseases and fractures; * Individuals diagnosed with infectious diseases such as HIV, tuberculosis, malaria, etc.; * Individuals with mental and neurological disorders including anorexia nervosa; * Individuals who have attempted weight loss or gain through various methods in the past three months; * Individuals in preconception, pregnancy, and lactation periods; * Individuals with autism and those with metal implants in their bodies.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences Shenzhen Guangdong Recruiting

More Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06923163 on ClinicalTrials.gov ↗ ← All trials in China